Bathi sadurunge bunga, pajak, lan amortisasi: cardiffoncology.com (CRDF)
Cardiff Oncology, Inc. (CRDF) delegates production and testing to external partners to focus on tumor therapy. Current EBITDA levels demonstrate peak profitability, while 0.00 captures the real-time status of the parameter. The issuer is implementing ESG standards to reduce the carbon footprint in medicine, maintaining strict oversight of contract firms to eliminate operational disruptions during molecule research.
Ringkesan rincian data analitis Cardiff Oncology (CRDF)
- kuotasi lan prakiraan analis:
- indikator kapitalisasi bursa perusahaan:
- data kapitalisasi buku:
- data tingkat utang lan likuiditas finansial:
Utang marang Modal Cardiff Oncology, Inc.|CRDF - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Cardiff Oncology Inc.|CRDF - Utang perusahaan|Utang-utang marang nilai buku Cardiff Oncology|CRDF - Utang jangka dawa perusahaan|Tanggungan jangka cendhak Cardiff Oncology|Likuiditas darurat cardiffoncology.com
- indikator bathi lan kelipatan valuasi:
CRDF - Penghasilan resik|Penghasilan resik sing dikarepake Cardiff Oncology, Inc.|CRDF - Koefisien rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep Cardiff Oncology Inc.|CRDF - Pangali PEG|Nilai bisnis marang bathi operasional sadurunge panyusutan Cardiff Oncology|CRDF - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Cardiff Oncology|CRDF - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan cardiffoncology.com|CRDF - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Cardiff Oncology, Inc.
- indikator pendapatan dodolan lan penghasilan bisnis:
Analisis kabeh metrik perusahaan:Cardiff Oncology, Inc.
This metric measures actual cash flow from core operations, excluding non-cash charges and financial manipulations to assess true operational efficiency. By analyzing absolute EBITDA, an investor can compare the current costs incurred by Cardiff Oncology, Inc. (CRDF) for the development of the PLK1 inhibitor with the company's potential future pricing power upon the drug's commercialization.
Karo sapa Cardiff Oncology, Inc. saingan
Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi INCY|HCM - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi nuvationbio.com|Day One Biopharmaceuticals (DAWN) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge amortisasi MNPR|INBX (Inhibrx Biosciences Inc) - Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi I-Mab Inc. (IMAB)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Fennec Pharmaceuticals (FENC)|HRTX - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Nuvectis Pharma NVCT|Coherus - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|CRBP - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi BeyondSpring Inc|BCAB: Bathi operasional EBITDA|Bathi operasional sadurunge potongan amortisasi lixte.com LIXT|Bathi operasional sadurunge ngurangi amortisasi CTXR|Bathi sadurunge bunga, pajak, lan amortisasi Cellectar Biosciences Inc CLRB|Bathi operasional sadurunge ngurangi amortisasi BLRX (BioLineRx Corp)|CANF (Can-Fite) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Aprea Therapeutics, Inc. - Bathi operasional sadurunge ngurangi amortisasi|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi KZIA (Kazia Therapeutics Ltd)|Silexion - Bathi operasional EBITDA|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi NCNA (NuCana plc)|CMRX: Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Cyclacel, Inc. (CYCC)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi G1 Therapeutics Inc.|KRON: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA KTRA|Bathi operasional EBITDA Oncternal Therapeutics Inc (ONCT)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Portage PRTG
